For Prostate Cancer Awareness Month, we sat down with Margaret Yu, M.D., Vice President, Disease Area Leader, Prostate Cancer,Janssen Research & Development, to learn more about the latest scientific strides being made in the battle against one of the most common cancers in men.
Johnson & Johnson's Chief Human Resources Officer reflects on a life-changing trip he took to Dhaka with the organization—and announces a new $5 million pledge to Save the Children's Centennial Commitment.
Johnson & Johnson has been instrumental in helping bring us closer to a TB-free world through its groundbreaking work with multidrug-resistant TB—and now a promising single-pill treatment that's being investigated.
From working to broaden the pool of patients trials have traditionally studied to finding ways for people to participate from the comforts of home, we look at how the company is reinventing clinical trials in truly forward-thinking ways.
Malaria. Newborn jaundice. Hearing loss. These are just some of the health problems that the winners of this year's Johnson & Johnson Africa Innovation Challenge are tackling by leveraging everything from apps to a smart formula for soap.
In the early 1980s, Cliff Morrison did what no other San Francisco General Hospital staff member had the guts to do: come up with a humane way to treat and care for AIDS patients. We sat down with him to learn more about the life-changing initiative to practice compassionate nursing—and how the legacy of Ward 5B lives on.
Announced ahead of the International AIDS Society Conference on HIV Science in Mexico City, the new study will evaluate an investigational vaccine regimen in eight countries around the world for its ability to protect people from HIV infection.